| 1 |
24325778 | Simvastatin and bezafibrate increase cholesterol efflux in men with type 2 diabetes. | 2014 |
1 |
| 2 |
12595494 | PPAR agonists protect mesangial cells from interleukin 1beta-induced intracellular lipid accumulation by activating the ABCA1 cholesterol efflux pathway. | 2003 Mar |
1 |
| 3 |
11483875 | Improvement in endothelial dysfunction in patients with hypoalphalipoproteinemia and coronary artery disease treated with bezafibrate. | 2001 Aug |
1 |
| 4 |
10751747 | Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus. | 2000 Mar-Apr |
1 |
| 5 |
11073848 | Bezafibrate increases prebeta 1-HDL at the expense of HDL2b in hypertriglyceridemia. | 2000 Nov |
2 |
| 6 |
11426588 | Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients. | 2000 |
1 |
| 7 |
9678787 | Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia. | 1998 May |
4 |
| 8 |
1397477 | Comparison of the effects of bezafibrate and acipimox on the lipid pattern and plasma fibrinogen in hyperlipidaemic type 2 (non-insulin-dependent) diabetic patients. | 1992 May-Jun |
1 |
| 9 |
7236016 | Effect of bezafibrate on the high-density lipoprotein subfractions HDL2 and HDL3 in primary hyperlipoproteinemia type IV. | 1980 |
1 |